Cabergoline Improves Metabolic Status in Hyperprolactinemia ...Middle East

News by : (Medscape) -
A single-center, observational study suggests that 6 months of treatment with the dopamine agonist cabergoline improves cardiometabolic measures in patients with a prolactinoma and hyperprolactinemia. First Look

Hence then, the article about cabergoline improves metabolic status in hyperprolactinemia was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Cabergoline Improves Metabolic Status in Hyperprolactinemia )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار